Moderna receives FDA approval for RSV vaccine mRESVIA

Moderna announced that the U.S. Food and Drug Administration has approved mRESVIA, an mRNA respiratory syncytial virus vaccine, to protect adults aged 60 years and older from lower respiratory tract [...]